[go: up one dir, main page]

AU2001252574A1 - Novel bicyclic compounds - Google Patents

Novel bicyclic compounds

Info

Publication number
AU2001252574A1
AU2001252574A1 AU2001252574A AU2001252574A AU2001252574A1 AU 2001252574 A1 AU2001252574 A1 AU 2001252574A1 AU 2001252574 A AU2001252574 A AU 2001252574A AU 2001252574 A AU2001252574 A AU 2001252574A AU 2001252574 A1 AU2001252574 A1 AU 2001252574A1
Authority
AU
Australia
Prior art keywords
bicyclic compounds
novel bicyclic
novel
compounds
bicyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2001252574A
Other versions
AU2001252574B2 (en
Inventor
Shunichi Ikuta
Shiro Miyoshi
Kohei Ogawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Pharma Corp
Original Assignee
Asahi Kasei Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Kasei Pharma Corp filed Critical Asahi Kasei Pharma Corp
Priority claimed from PCT/JP2001/003575 external-priority patent/WO2001083451A1/en
Publication of AU2001252574A1 publication Critical patent/AU2001252574A1/en
Assigned to ASAHI KASEI PHARMA CORPORATION reassignment ASAHI KASEI PHARMA CORPORATION Request for Assignment Assignors: ASAHI KASEI KABUSHIKI KAISHA
Application granted granted Critical
Publication of AU2001252574B2 publication Critical patent/AU2001252574B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2001252574A 2000-04-28 2001-04-25 Novel bicyclic compounds Ceased AU2001252574B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000130414 2000-04-28
JP2000-130414 2000-04-28
PCT/JP2001/003575 WO2001083451A1 (en) 2000-04-28 2001-04-25 Novel bicyclic compounds

Publications (2)

Publication Number Publication Date
AU2001252574A1 true AU2001252574A1 (en) 2002-01-31
AU2001252574B2 AU2001252574B2 (en) 2005-03-17

Family

ID=18639529

Family Applications (2)

Application Number Title Priority Date Filing Date
AU5257401A Pending AU5257401A (en) 2000-04-28 2001-04-25 Novel bicyclic compounds
AU2001252574A Ceased AU2001252574B2 (en) 2000-04-28 2001-04-25 Novel bicyclic compounds

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU5257401A Pending AU5257401A (en) 2000-04-28 2001-04-25 Novel bicyclic compounds

Country Status (12)

Country Link
US (2) US6861444B2 (en)
EP (1) EP1277736B1 (en)
KR (1) KR100502876B1 (en)
CN (1) CN1430603A (en)
AT (1) ATE369337T1 (en)
AU (2) AU5257401A (en)
CA (1) CA2407538C (en)
DE (1) DE60129806T2 (en)
DK (1) DK1277736T3 (en)
ES (1) ES2287120T3 (en)
PT (1) PT1277736E (en)
WO (1) WO2001083451A1 (en)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002074306A1 (en) * 2001-03-19 2002-09-26 Asahi Kasei Kabushiki Kaisha Remedies for fatty liver
HUP0401318A3 (en) * 2001-08-22 2008-03-28 Sanofi Aventis Deutschland Combined preparations containing 2,3,4,5-tetrahydro-benzo[b]thiepine-1,1-dioxide derivatives and other active substances, and the use thereof
US7399777B2 (en) 2001-08-31 2008-07-15 Sanofi-Aventis Deutschland Gmbh Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmceuticals
IL160556A0 (en) 2001-08-31 2004-07-25 Aventis Pharma Gmbh Diaryl cycloalkyl derivatives, method for producing the same and the use thereof as ppar activators
US6884812B2 (en) 2001-08-31 2005-04-26 Aventis Pharma Deutschland Gmbh Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmaceuticals
CN100347158C (en) * 2001-10-25 2007-11-07 旭化成制药株式会社 bicyclic compound
US7078541B2 (en) * 2002-02-07 2006-07-18 Galileo Pharmaceuticals, Inc. Benzofuran derivatives
US7223796B2 (en) 2002-04-11 2007-05-29 Sanofi-Aventis Deutschland Gmbh Acyl-4-carboxyphenylurea derivatives, processes for preparing them and their use
US7078404B2 (en) 2002-04-11 2006-07-18 Sanofi-Aventis Deutschland Gmbh Acyl-3-carboxyphenylurea derivatives, processes for preparing them and their use
US7049341B2 (en) 2002-06-07 2006-05-23 Aventis Pharma Deutschland Gmbh N-benzoylureidocinnamic acid derivatives, processes for preparing them and their use
DE10231370B4 (en) 2002-07-11 2006-04-06 Sanofi-Aventis Deutschland Gmbh Thiophene glycoside derivatives, medicaments containing these compounds and methods of making these medicaments
US7262220B2 (en) 2002-07-11 2007-08-28 Sanofi-Aventis Deutschland Gmbh Urea- and urethane-substituted acylureas, process for their preparation and their use
AU2003249937A1 (en) 2002-07-12 2004-02-02 Sanofi-Aventis Deutschland Gmbh Heterocyclically substituted benzoylureas, method for their production and their use as medicaments
US20040157922A1 (en) 2002-10-04 2004-08-12 Aventis Pharma Deutschland Gmbh Carboxyalkoxy-substituted acyl-carboxyphenylurea derivatives and their use as medicaments
US7208504B2 (en) 2002-10-12 2007-04-24 Sanofi-Aventis Deutschland Gmbh Bicyclic inhibitors of hormone sensitive lipase
DE10258007B4 (en) 2002-12-12 2006-02-09 Sanofi-Aventis Deutschland Gmbh Aromatic fluoroglycoside derivatives, medicaments containing these compounds and methods for the preparation of these medicaments
DE10258008B4 (en) * 2002-12-12 2006-02-02 Sanofi-Aventis Deutschland Gmbh Heterocyclic fluoroglycoside derivatives, medicaments containing these compounds and methods of making these medicaments
US20040242583A1 (en) 2003-01-20 2004-12-02 Aventis Pharma Deutschland Gmbh Pyrimido[5,4-e][1,2,4]triazine-5,7-diones, processes for preparing them and their use
US7179941B2 (en) 2003-01-23 2007-02-20 Sanofi-Aventis Deutschland Gmbh Carbonylamino-substituted acyl phenyl urea derivatives, process for their preparation and their use
DE10306250A1 (en) 2003-02-14 2004-09-09 Aventis Pharma Deutschland Gmbh Substituted N-aryl heterocycles, processes for their preparation and their use as pharmaceuticals
DE10308352A1 (en) 2003-02-27 2004-09-09 Aventis Pharma Deutschland Gmbh Branched side chain arylcycloalkyl derivatives, process for their preparation and their use as medicaments
DE10308355A1 (en) 2003-02-27 2004-12-23 Aventis Pharma Deutschland Gmbh Aryl-cycloalkyl-substituted alkanoic acid derivatives, process for their preparation and their use as medicaments
DE10308351A1 (en) 2003-02-27 2004-11-25 Aventis Pharma Deutschland Gmbh 1,3-substituted cycloalkyl derivatives having acidic, usually heterocyclic groups, processes for their preparation and their use as medicaments
US7148246B2 (en) 2003-02-27 2006-12-12 Sanofi-Aventis Deutschland Gmbh Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals
DE10308353A1 (en) 2003-02-27 2004-12-02 Aventis Pharma Deutschland Gmbh Diarylcycloalkyl derivatives, processes for their preparation and their use as medicines
US7501440B2 (en) 2003-03-07 2009-03-10 Sanofi-Aventis Deutschland Gmbh Substituted benzoylureidopyridylpiperidine-and-pyrrolidinecarboxylic acid derivatives, processes for preparing them and their use
DE10314610A1 (en) 2003-04-01 2004-11-04 Aventis Pharma Deutschland Gmbh New diphenylazetidinone with improved physiological properties, process for its preparation, medicaments containing these compounds and its use
US7094800B2 (en) 2003-07-25 2006-08-22 Sanofi-Aventis Deutschland Gmbh Cyanopyrrolidides, process for their preparation and their use as medicaments
US7008957B2 (en) 2003-07-25 2006-03-07 Sanofi-Aventis Deutschland Gmbh Bicyclic cyanoheterocycles, process for their preparation and their use as medicaments
US7094794B2 (en) 2003-07-28 2006-08-22 Sanofi-Aventis Deutschland Gmbh Substituted thiazole-benzoisothiazole dioxide derivatives, process for their preparation and their use
DE10335092B3 (en) 2003-08-01 2005-02-03 Aventis Pharma Deutschland Gmbh Substituted benzoylureido-o-benzoylamides, process for their preparation and their use
US7241787B2 (en) 2004-01-25 2007-07-10 Sanofi-Aventis Deutschland Gmbh Substituted N-cycloexylimidazolinones, process for their preparation and their use as medicaments
US7470706B2 (en) 2004-01-31 2008-12-30 Sanofi-Aventis Deutschland Gmbh Cycloalkyl-substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments
US7498341B2 (en) 2004-01-31 2009-03-03 Sanofi Aventis Deutschland Gmbh Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments
US7402674B2 (en) 2004-01-31 2008-07-22 Sanofi-Aventis Deutschland Gmbh, 7-Phenylamino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments
DE102004005172A1 (en) 2004-02-02 2005-08-18 Aventis Pharma Deutschland Gmbh Indazole derivatives as inhibitors of the hormone sensitive lipase
EP1586573B1 (en) 2004-04-01 2007-02-07 Sanofi-Aventis Deutschland GmbH Oxadiazolones, processes for their preparation and their use as pharmaceuticals
KR100592805B1 (en) * 2004-04-13 2006-06-26 한국화학연구원 Indene derivatives and preparation method thereof
DE102004021779A1 (en) * 2004-04-30 2005-11-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg New beta-agonists, process for their preparation and their use as medicines
EA200700243A1 (en) 2004-07-14 2007-08-31 ПиТиСи ТЕРАПЬЮТИКС, ИНК. METHODS OF TREATMENT OF HEPATITIS C
US7868037B2 (en) 2004-07-14 2011-01-11 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7772271B2 (en) 2004-07-14 2010-08-10 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
CA2578636A1 (en) 2004-07-22 2006-02-23 Ptc Therapeutics, Inc. Thienopyridines for treating hepatitis c
WO2006132196A1 (en) * 2005-06-08 2006-12-14 Asahi Kasei Pharma Corporation NOVEL PHARMACEUTICAL COMPRISING β3 AGONIST
DE102005026762A1 (en) 2005-06-09 2006-12-21 Sanofi-Aventis Deutschland Gmbh Azolopyridin-2-one derivatives as inhibitors of lipases and phospholipases
DE102005052127A1 (en) 2005-10-28 2007-05-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Novel indole beta-agonists, process for their preparation and their use as pharmaceuticals
DE102005052102A1 (en) * 2005-10-28 2007-05-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg New beta-agonists, process for their preparation and their use as medicines
WO2007106537A2 (en) 2006-03-13 2007-09-20 Activx Biosciences, Inc. Aminoquinolones as gsk-3 inhibitors
DE102006028862A1 (en) 2006-06-23 2007-12-27 Merck Patent Gmbh 3-amino-imidazo [1,2-a] pyridine
EP2061767B1 (en) 2006-08-08 2014-12-17 Sanofi Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for preparing them, medicaments comprising these compounds, and their use
DE102007002260A1 (en) 2007-01-16 2008-07-31 Sanofi-Aventis Use of substituted pyranonic acid derivatives for the preparation of medicaments for the treatment of the metabolic syndrome
DE102007008420A1 (en) 2007-02-21 2008-08-28 Merck Patent Gmbh benzimidazole derivatives
CN103450077B (en) 2007-06-08 2016-07-06 满康德股份有限公司 IRE-1 alpha inhibitor
EP2025674A1 (en) 2007-08-15 2009-02-18 sanofi-aventis Substituted tetra hydro naphthalines, method for their manufacture and their use as drugs
WO2009035634A2 (en) 2007-09-11 2009-03-19 Activx Biosciences, Inc. Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors
CN101855229A (en) 2007-09-12 2010-10-06 埃迪威克斯生物科学公司 Spirocyclic aminoquinolones as GSK-3 inhibitors
DE102007048716A1 (en) 2007-10-11 2009-04-23 Merck Patent Gmbh Imidazo [1,2-a] pyrimidine derivatives
DE102007054497B3 (en) 2007-11-13 2009-07-23 Sanofi-Aventis Deutschland Gmbh Novel crystalline diphenylazetidinone hydrates and process for their preparation
DE102008017590A1 (en) 2008-04-07 2009-10-08 Merck Patent Gmbh Glucopyranosidderivate
US8470841B2 (en) 2008-07-09 2013-06-25 Sanofi Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
CN102171192A (en) 2008-10-09 2011-08-31 旭化成制药株式会社 Indazole compound
WO2010041568A1 (en) 2008-10-09 2010-04-15 旭化成ファーマ株式会社 Indazole derivative
US20100222404A1 (en) * 2008-11-04 2010-09-02 Asahi Kasei Pharma Corporation Indazole derivative dihydrochloride
WO2010068601A1 (en) 2008-12-08 2010-06-17 Sanofi-Aventis A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
KR101748891B1 (en) 2009-03-11 2017-06-19 교린 세이야꾸 가부시키 가이샤 7-cycloalkylaminoquinolones as gsk-3 inhibitors
CN102482312A (en) 2009-08-26 2012-05-30 赛诺菲 Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use
US20120225909A1 (en) * 2009-09-30 2012-09-06 Asahi Kasei Pharma Corporation Indazole analog
CN102753184A (en) 2009-10-02 2012-10-24 赛诺菲 Use of compounds with sglt-1/sglt-2 inhibitor activity for producing medicaments for treatment of bone diseases
US8748433B2 (en) * 2010-04-30 2014-06-10 Merck Sharp & Dohme Corp. β3 adrenergic receptor agonists
EP2683702B1 (en) 2011-03-08 2014-12-24 Sanofi New substituted phenyl oxathiazine derivatives, method for their manufacture, medicines containing these compounds and their application
WO2012120056A1 (en) 2011-03-08 2012-09-13 Sanofi Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
EP2683703B1 (en) 2011-03-08 2015-05-27 Sanofi Novel substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
EP2683699B1 (en) 2011-03-08 2015-06-24 Sanofi Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
US8901114B2 (en) 2011-03-08 2014-12-02 Sanofi Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof
US8846666B2 (en) 2011-03-08 2014-09-30 Sanofi Oxathiazine derivatives which are substituted with benzyl or heteromethylene groups, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
EP2683705B1 (en) 2011-03-08 2015-04-22 Sanofi Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
WO2012120053A1 (en) 2011-03-08 2012-09-13 Sanofi Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
WO2012120051A1 (en) 2011-03-08 2012-09-13 Sanofi Benzyl-oxathiazine derivates substituted with adamantane or noradamantane, medicaments containing said compounds and use thereof
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201903832D0 (en) 2019-03-20 2019-05-01 Atrogi Ab New compounds and methods

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2257273B1 (en) * 1974-01-15 1978-01-13 Labaz
DE2429253A1 (en) 1974-06-19 1976-01-15 Boehringer Sohn Ingelheim PHENYLAL CANOLAMINE
FR2332010A1 (en) 1975-11-18 1977-06-17 Continental Pharma HETEROCYCLIC AMINO-ALCOHOL, ITS SALT AND ITS PREPARATION PROCESS
JPS5553262Y2 (en) 1976-11-08 1980-12-10
JPS5841860Y2 (en) 1978-04-05 1983-09-21 三菱電機株式会社 rice cooker
JPS5553262A (en) 1978-10-17 1980-04-18 Yamanouchi Pharmaceut Co Ltd Phenylethanolamine derivative
DE3061334D1 (en) * 1979-06-16 1983-01-20 Beecham Group Plc Ethanamine derivatives, their preparation and use in pharmaceutical compositions
US4816457A (en) * 1980-12-23 1989-03-28 Baldwin John J Aralkylaminoethanol heterocyclic compounds
JPS5950671B2 (en) 1982-08-26 1984-12-10 山之内製薬株式会社 Phenylethanolamine derivative and method for producing the same
GB8419797D0 (en) 1984-08-03 1984-09-05 Beecham Group Plc Compounds
US5061727A (en) 1990-05-04 1991-10-29 American Cyanamid Company Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles
FR2688136B1 (en) * 1992-03-03 1995-06-09 Oreal COSMETIC COMPOSITION CONTAINING MELANIC PIGMENTS IN ASSOCIATION WITH CERTAIN TOCOPHEROLS, AND METHOD FOR PROTECTING THE SKIN, HAIR, MUCOSA AND COSMETIC COMPOSITIONS.
ATE154935T1 (en) * 1993-06-14 1997-07-15 Pfizer SECOND AMINE AS ANTIDIABETIC AGENTS AND FOR THE TREATMENT OF OBESITY
US5776983A (en) 1993-12-21 1998-07-07 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
US5541197A (en) * 1994-04-26 1996-07-30 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
JPH08165276A (en) 1994-12-14 1996-06-25 Dainippon Pharmaceut Co Ltd 2-alkylamino-1-phenylethanol derivative
JPH11504648A (en) * 1995-05-10 1999-04-27 ファイザー・インコーポレーテッド β-adrenergic agonist
US6103236A (en) * 1995-05-10 2000-08-15 Kyowa Hakko Kogyo Co., Ltd. Toxin conjugates
WO1996035671A1 (en) * 1995-05-10 1996-11-14 Pfizer Inc. β-ADRENERGIC AGONISTS
CA2242351C (en) 1996-01-10 2003-03-11 Asahi Kasei Kogyo Kabushiki Kaisha Novel tricyclic compounds and drug compositions containing the same
PT901483E (en) * 1996-05-14 2003-11-28 Glaxo Group Ltd BENZOFURANES AND BENZOPIRANOS AS CHRONOBIOLOGICAL AGENTS
EP0822185A1 (en) * 1996-07-31 1998-02-04 Pfizer Inc. B-3-adrenergic agonists as antidiabetic and antiobesity agents
ES2149742T1 (en) * 1997-07-03 2000-11-16 Asahi Chemical Ind NEW TRICYCLIC COMPOUNDS THAT HAVE SATURATED RINGS AND MEDICINAL COMPOSITIONS THAT CONTAIN THEM.
CA2355079A1 (en) 1998-12-15 2000-06-22 Shiro Miyoshi Novel heterocyclic compounds and drug compositions containing the same
TW519537B (en) 1999-03-26 2003-02-01 Asahi Chemical Ind Process for the preparation of tricylic amino-alcohol derivatives
KR20020069215A (en) 1999-12-16 2002-08-29 아사히 가세이 가부시키가이샤 Novel Substituted Tricyclic Compounds

Similar Documents

Publication Publication Date Title
AU2001252574A1 (en) Novel bicyclic compounds
AU2002218266A1 (en) Novel indanylidene compounds
AU2002323787A1 (en) Spiro compounds
AU2002349297A1 (en) Statin-like compounds
AU2002225730A1 (en) Compounds
AU2001292518A1 (en) Novel compounds
AU2002352221A1 (en) Bicyclic n-arylamides
AU2002359165A1 (en) Novel compounds
AU2002336311A1 (en) Bicyclic compound
AU2001239765A1 (en) Novel compounds
AUPQ661800A0 (en) Insulin-potentiating compounds
AU2001246998A1 (en) Novel compounds
AU2001253362A1 (en) Novel compounds
AU2002231077A1 (en) Novel compounds
AU2001288110A1 (en) Spiro compounds
AU2001256964A1 (en) Novel compounds
AU2002225724A1 (en) Motilide compounds
AU2001252575A1 (en) Novel tricyclic compounds
AU2002217285A1 (en) Compounds
AU2001230689A1 (en) Novel compounds
AU2002216060A1 (en) Novel compounds
AU2002221923A1 (en) Novel compounds
AU2001276890A1 (en) Novel compounds
AU2001258760A1 (en) Novel thiophenamide compounds
AU2001237533A1 (en) Novel p-gp-inhibiting compounds